![Robert Schotzinger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Schotzinger
No open positions remaining
Profile
Robert J.
Schotzinger was the founder of Viamet Pharmaceuticals, Inc., founded in 2007, where the titles held included President & Chief Executive Officer from 2007 to 2014.
Current jobs include Chairman & Chief Executive Officer at Eldec Pharmaceuticals, Inc. starting in 2024; Director at Innocrin Pharmaceuticals Holdings LLC; Director at Innocrin Pharmaceuticals, Inc.; Director at Arrevus, Inc. since 2019; and Director at Propella Therapeutics, Inc. Former jobs include President & Chief Executive Officer at BioStratum, Inc., President, Chief Executive Officer & Director at Viamet Pharmaceuticals Corp., and Vice President-Drug Development at Abbott Laboratories.
Education includes a doctorate from Case Western Reserve University and an undergraduate degree from The Ohio State University.
Robert Schotzinger active positions
| Companies | Position | Start |
|---|---|---|
Innocrin Pharmaceuticals, Inc.
 Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral inhibitors for the treatment of castration-resistant prostate cancer | Director/Board Member | - |
Innocrin Pharmaceuticals Holdings LLC
 Innocrin Pharmaceuticals Holdings LLC Medical SpecialtiesHealth Technology Discovers and develops oral inhibitors for the treatment of castration-resistant prostate cancer | Director/Board Member | - |
Propella Therapeutics, Inc.
 Propella Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that has developed a platform that combines medicinal chemistry | Director/Board Member | - |
Former positions of Robert Schotzinger
| Companies | Position | End |
|---|---|---|
Arrevus, Inc.
 Arrevus, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies for orphan infectious diseases | Director/Board Member | - |
Viamet Pharmaceuticals Corp.
 Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using proprietary metalloenzyme medicinal chemistry | Chief Executive Officer | - |
Viamet Pharmaceuticals, Inc.
 Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops inhibitors of validated metalloenzymes | Founder | - |
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
BioStratum, Inc.
 BioStratum, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | President | - |
Education of Robert Schotzinger
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
16
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Viamet Pharmaceuticals, Inc.
Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops inhibitors of validated metalloenzymes | Health Technology |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using proprietary metalloenzyme medicinal chemistry | Health Technology |
Innocrin Pharmaceuticals Holdings LLC
Innocrin Pharmaceuticals Holdings LLC Medical SpecialtiesHealth Technology Discovers and develops oral inhibitors for the treatment of castration-resistant prostate cancer | Health Technology |
BioStratum, Inc.
BioStratum, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Case Western Reserve University
 Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innocrin Pharmaceuticals, Inc.
Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral inhibitors for the treatment of castration-resistant prostate cancer | Health Technology |
Arrevus, Inc.
Arrevus, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies for orphan infectious diseases | Health Technology |
Propella Therapeutics, Inc.
Propella Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that has developed a platform that combines medicinal chemistry | Health Technology |
- Stock Market
- Insiders
- Robert Schotzinger
